The market performance of Harvard Bioscience Inc has been somewhat unstable. Over the past year, the company’s stock achieved a high of $3.60 on 07/17/24, with the lowest value for the same timeframe being $0.28, recorded on 05/28/25.
52-week price history of HBIO Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Harvard Bioscience Inc’s current trading price is -87.03% away from its 52-week high, while its distance from the 52-week low is 66.01%. The stock’s price range for this period has remained between $0.28 and $3.60. The Healthcare sector company’s shares managed to surpass a trading volume of around 13.24 million for the day, which was noticeably higher compared to the shares’ average daily volume of 10.86 million over the last three months.
Financial Performance and Market Capitalization
Harvard Bioscience Inc (HBIO) has experienced a quarterly decline of -44.64% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 20.65M and boasts a workforce of 355 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.8876, with a change in price of -1.6730. Similarly, Harvard Bioscience Inc recorded 6,974,769 in trading volume during the last 100 days, posting a change of -78.18%.
HBIO Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for HBIO stands at 3.01. Similarly, the long-term debt-to-equity ratio is also 0.49.
HBIO Stock Stochastic Average
As of today, the raw stochastic average of Harvard Bioscience Inc over the past 50 days is 27.77%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 27.77%. Additionally, the Stochastic %K and %D values for the company were 28.89% and 22.48%, respectively, over the past 20 days.
HBIO Stock Price Performance Analysis
The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. This year’s metric has recorded a Price decrease of -77.87%. However, over the past six months, we’ve seen a stronger performance of -79.15%. The price of HBIO fallen by 31.07% over the last 30 days. And in the last five days, it has surged by 41.43%.
